Cancer doesn’t take a break, neither do we
While the world focused on Covid-19 testing, cancer did not take a break. We’re so relieved that priorities are now diversifying to include important routine testing for cancer and other hereditary diseases. Patients all over the world will be able to receive diagnosis and begin treatment. On the shipping table today are also test kits headed for laboratories worldwide including Italy, the Czech Republic and China.